Chile vs Panama: Cause of death, by non-communicable diseases, ages 60+, female
Chile
78.9%
in 2021
Panama
78.7%
in 2021
Chile rank
65th
Panama rank
66th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Chile
- Panama
How they compare
Chile currently reports 78.9% against 78.7% in Panama, a difference of 0.2%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Panama ahead.
Chile ranks 65th and Panama ranks 66th of 185 countries.
Across the 3 decades both report, Chile averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Chile | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.7% | 92.2% | 5.5% | Panama |
| 2010s | 89.0% | 90.4% | 1.4% | Panama |
| 2020s | 78.5% | 76.3% | 2.2% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Chile or Panama?
- Chile, at 78.9% against 78.7% in Panama as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Chile and Panama?
- 0.2%, with Chile ahead.
- How many years of comparable data are there for Chile and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Panama rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Chile ranks 65th and Panama ranks 66th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.